SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Trickett Sara

(Last)

(First)

(Middle)

1 HANCOCK ST.

(Street)

PORTLAND

04101

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/22/2024

3. Issuer Name and Ticker or Trading Symbol
WEX Inc. [ WEX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	SVP, Acting General Counsel

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	887	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Units	⁽¹⁾	⁽¹⁾	Common Stock	165	$0	D
Restricted Stock Units	⁽²⁾	⁽²⁾	Common Stock	266	$0	D
Restricted Stock Units	⁽³⁾	⁽³⁾	Common Stock	1,153	$0	D
Restricted Stock Units	⁽⁴⁾	⁽⁴⁾	Common Stock	1,061	$0	D
Stock Option (right to buy)	03/15/2023⁽⁵⁾	03/15/2032	Common Stock	565	$163.22	D
Stock Option (right to buy)	03/15/2024⁽⁶⁾	03/15/2033	Common Stock	564	$173.56	D

Explanation of Responses:

1. RSUs vest with respect to 82 units on March 15, 2024, and 83 units on March 15, 2025.

2. RSUs vest with respect to 88 units on March 15, 2024, 89 units on March 15, 2025, and 89 units on March 15, 2026.

3. RSUs vest with respect to 1,153 units on March 15, 2024.

4. RSUs vest with respect to 530 units on December 15, 2024, and 531 units on December 15, 2025.

5. This option became exercisable with respect to 188 shares on March 15, 2023, and becomes exercisable with respect to 188 shares on March 15, 2024 and 189 shares on March 15, 2025.

6. This option becomes exercisable with respect to 187 shares on March 15, 2024, 188 shares on March 15, 2025, and 189 shares on March 15, 2026.

Remarks:

EXHIBIT LIST: EX-24 POA - ST

	/s/ Timothy Bergeron, as attorney-in-fact for Sara Trickett	02/01/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.